This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adolphe, C. Articles by Wainwright, B. Search for Related Content PubMed PubMed Citation Articles by Adolphe, C. Articles by Wainwright, B.

Patched1 Functions as a Gatekeeper by Promoting Cell Cycle Progression

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia

Requests for reprints: Brandon Wainwright, Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Road, Brisbane, Queensland, Australia 4072. Phone: 61-7-3346-2053; Fax: 61-7-3346-2101; E-mail: B.Wainwright{at}imb.uq.edu.au.

Mutations in the Hedgehog receptor, Patched 1 (Ptch1), have been linked to both familial and sporadic forms of basal cell carcinoma (BCC), leading to the hypothesis that loss of Ptch1 function is sufficient for tumor progression. By combining conditional knockout technology with the inducible activity of the Keratin6 promoter, we provide in vivo evidence that loss of Ptch1 function from the basal cell population of mouse skin is sufficient to induce rapid skin tumor formation, reminiscent of human BCC. Elimination of Ptch1 does not promote the nuclear translocation of ß-catenin and does not induce ectopic activation or expression of Notch pathway constituents. In the absence of Ptch1, however, a large proportion of basal cells exhibit nuclear accumulation of the cell cycle regulators cyclin D1 and B1. Collectively, our data suggest that Ptch1 likely functions as a tumor suppressor by inhibiting G₁-S phase and G₂-M phase cell cycle progression, and the rapid onset of tumor progression clearly indicates Ptch1 functions as a "gatekeeper." In addition, we note the high frequency and rapid onset of tumors in this mouse model makes it an ideal system for testing therapeutic strategies, such as Patched pathway inhibitors. (Cancer Res 2006; 66(4): 2081-8)

This article has been cited by other articles:

				X. Jiang, P. Yang, and L. Ma Kinase activity-independent regulation of cyclin pathway by GRK2 is essential for zebrafish early development PNAS, June 23, 2009; 106(25): 10183 - 10188. [Abstract] [Full Text] [PDF]

				R. C. Moraes, H. Chang, N. Harrington, J. D. Landua, J. T. Prigge, T. F. Lane, B. J. Wainwright, P. A. Hamel, and M. T. Lewis Ptch1 is required locally for mammary gland morphogenesis and systemically for ductal elongation Development, May 1, 2009; 136(9): 1423 - 1432. [Abstract] [Full Text] [PDF]

				D. Marsh, S. Dickinson, G. W. Neill, J. F. Marshall, I. R. Hart, and G. J. Thomas {alpha}v{beta}6 Integrin Promotes the Invasion of Morphoeic Basal Cell Carcinoma through Stromal Modulation Cancer Res., May 1, 2008; 68(9): 3295 - 3303. [Abstract] [Full Text] [PDF]

				J. J. Trowbridge, M. P. Scott, and M. Bhatia Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration PNAS, September 19, 2006; 103(38): 14134 - 14139. [Abstract] [Full Text] [PDF]